Android app on Google Play

Trius Therapeutics (TSRX) Announces Common Stock Offering

January 17, 2013 4:25 PM EST Send to a Friend
Get Alerts TSRX Hot Sheet
Trade TSRX Now!
Join SI Premium – FREE
Trius Therapeutics, Inc. (Nasdaq: TSRX) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Citigroup and Leerink Swann are acting as joint book-running managers and Baird is acting as a co-lead manager. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

The securities described above are being offered by Trius pursuant to two shelf registration statements previously filed with and declared effective by the Securities and Exchange Commission (the "SEC") on September 15, 2011 and September 11, 2012. Preliminary prospectus supplements related to the offering will be filed with the SEC.




You May Also Be Interested In


Related Categories

Equity Offerings

Related Entities

Citi, Robert W Baird

Add Your Comment